Scar Treatment Market Regional Landscape and Key Drivers Analysis by 2025

Industry Insights
The Global Scar Treatment Market size was worth USD 13.8 billion in 2015 which is anticipated to grow at a CAGR of more than 9.7% during the forecast period. Esthetic appearance among people is one of the major factors driving market growth. Scar treatment helps enhance the esthetic appeal of an individual through skin rejuvenating. Women are more concerned about esthetics, hence are expected to form the largest customer base for this market. Another major factor contributing to the growth of this market is the rising number of road accidents. According to WHO, approximately 10 million people are injured in road accidents every year.

This gives rise to high need for scar treatment products, such as topical products that help in reducing the scars effectively. Road accidents also increase the need for cosmetic surgical treatments, which in turn leads to high demand for laser instruments. Rising incidence of burn injuries also supports the growth of this market. Burn injuries contort the appearance of the victim, leaving noticeable hypertrophic burn marks. People with high disposable income, often go for surgical treatment to get rid of such marks. Thus, scar removal products help in treating burn injuries.

Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/scar-treatment-market/request-sample

Technological advancement, such as laser therapy is also accelerating the growth of this market. For instance, Cynosure came up with MedLite C6, a Q-switched laser device, which is used for treating acne and other skin diseases. These laser devices help in treating the marks by destroying the scar tissue. Reconstructive and plastic surgery is also considered as a part of the surgical laser treatment procedure, which has further expanded the market growth.

Product Insights
Based on product, topical products held the largest market share in 2016 and are expected to witness an attractive growth over the forecast period. It is due to the easy availability of these products Over-the-Counter (OTC), for instance, topical creams, gels and oils. Due to this reason, topical products are greatly used as a treatment for scars. Laser products are expected to witness a lucrative growth over the forecast period. This is due to the fact that non-invasive therapy facilitates less pain and discomfort. Laser-based cosmetic surgeries are also increasingly preferred by the patients who are experiencing stretch marks, acne and keloid.

Browse Full Research Report @
https://www.millioninsights.com/industry-reports/scar-treatment-market

Scar Type Insights
Based on scar type, atrophic scars dominated the market in 2015. This is because it majorly comprises acne scars. Most of the people, especially women are concerned about acne. Hence, there is a high demand for OTC products such as gels and topical creams for treating acne, thereby, making it a strong segment. Hypertrophic and keloid scars also held significant market share in 2015 owing to the growing number of wound injuries leading to these marks. OTC products such as silicone gels, topical creams and silicone gel sheets assist in minimizing the visibility of these marks.

End Use Insights
Based on end-use, the market is segmented into clinics, hospitals, e-commerce, and retail pharmacies. Among them, hospitals dominated the market in 2015. This is due to the wide usage of laser instruments, steroid injections and topical creams and gels in the hospital settings. Availability of specialists in the hospital also contributes to the growth of this segment. E-commerce/retail pharmacies are expected to witness lucrative growth over the forecast period. Online websites provide a wide variety of scar treatment products such as steroid injections, topical creams & gels and portable laser instruments. It also offers numerous lucrative offers and discounted prices, which further raises the growth of this segment. In retail pharmacies, topical products are available easily, which facilitates easy accessibility of scar treatment products.

See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices

Regional Insights
Based on region, North America held the largest market share in 2015. This is due to the growing acceptability of technologically advanced products and high concern among people regarding esthetic appeal. Huge demand for advanced laser instruments in the U.S. also drives the growth of this region. Asia Pacific is expected to witness a lucrative CAGR over the forecast period due to the rising incidence of road accidents in country like India. In addition, rising disposable income in these countries is also anticipated to contribute to the growth of this region.

Competitive Insights
Some of the major companies of the market are Lumenis; Mölnlycke Health Care; NewMedical Technology, Inc.; Sonoma Pharmaceuticals, Inc; Smith & Nephew plc; CCA Industries Inc.; Suneva Medical, Inc.; Enaltus LLC; Merz Inc. and Scarheal, Inc. The key companies go for strategic initiatives such as regional expansion, development of new products with improvised technology and mergers & acquisitions. For instance, Lumenis acquired Pollogen in 2015, in order to expand its product portfolio in the field of esthetics.

For More Detailed Analysis Visit @ Million Insights

Peripheral Vascular Device Market Key Country Analysis and Growth Forecast by 2020

Industry Insights
The Global Peripheral Vascular Device Market size was estimated at USD 5,888.5 million in 2014 and is expected to grow at a CAGR of 7.2% over the forecast period. Rising demand for minimally invasive procedures and growing aging population coupled with changing lifestyles are some of the key factors driving the growth of peripheral vascular device market. Increase in peripheral vascular diseases and technological advancements in the devices is also anticipated to further boost up the demand for these devices in the market. According to an estimate of Central Disease for Control and Prevention, about 8.5 million people in the U.S have peripheral artery disease including 12-20% of individuals ageing 60 years and above.

Furthermore, rising number of specialists treating peripheral vascular disease also propel the market growth of these devices. Introduction of technologically advanced products like drug eluting balloons further drive the future adoption of such devices. Rising chronic conditions including diabetes, obesity and end-stage renal disease is one of the crucial factors anticipated to boost demand for these devices. Some of the key advantages associated with these devices are minimal scarring and post-surgery infection that improves the adoption level of these devices among the patients. However, the market growth is expected to negatively impact the market owing to factors such as reimbursement issues in developing countries, stringent regulatory policies, and presence of highly fragmented market.

Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/peripheral-vascular-devices-market/request-sample

Product Insights
Based on the products, the market is segmented as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters. Peripheral vascular stents accounted for the major share of over 31% in 2014 pertaining to the factors such as rising incidences of peripheral artery disease and development of new imaging techniques. Introduction of technologically advanced stents such as drug eluting stents further boost up demand for such devices.

In addition, increase in need for therapies that reduce the risk of complications such as thrombosis is one of the factor contributing towards its growth. However, stringent product approval process, number of product failures, and presence of alternative treatment options for cardiac disease may restrain the growth of stents in the market. Peripheral angioplasty balloon catheters held significant market share owing to introduction of technological advance products like drug coated balloons and favorable reimbursement policies in developed countries like Germany and the U.S.

Browse Full Research Report @
https://www.millioninsights.com/industry-reports/peripheral-vascular-devices-market

Regional Insight
North America dominated the market with the maximum share of 39% in 2014 owing to rising healthcare expenditure, high R&D activities, favorable reimbursement policies, increasing awareness, and growing stent surgeries in the region. Asia pacific region is expected to be the fastest growing segment with a CAGR of 10% over the forecast period. The growth in the region is driven by the factors such rising incidence of cardiovascular disease, improving healthcare infrastructure, large population base unmet medical needs, and rising disposable income level in emerging countries like India and China. In addition, cost of surgery is less in this region as compared to developed nations that is expected to boost medical tourisms, which in turn anticipated to surge demand for such devices.

See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices

Competitive Insights
Few of the key participants of peripheral vascular devices market include, Edward Lifesciences Corporation; Abbott Laboratories; Angiocare, Inc.; Boston Scientific Corporation; Medtronic, Inc.; Teleflex Medical; St.Jude Medical; Volcano Corporation; Bayer; Terumo International System, Inc. ;B Braun, Inc.; Endologix; Volcano Corporation; W.L. Gore and Associates Ltd.; Angioscore Ltd, and Cordis Corporation.

For More Detailed Analysis Visit @ Million Insights

Deep Brain Stimulators (DBS) Market Scope, Regions, Types and Applications 2012-2020

Industry Insights
The global size for Deep Brain Stimulators (DBS) Market in 2016 was worth USD 618.6 million and is anticipated to grow with a CAGR 17.2% throughout the forecast period. The growth can be attributed to the high prevalence of neurological disorders such as Alzheimer’s disease, epilepsy, essential tremor, dystonia, Parkinson’s diseases and obsessive-compulsive disorders. This in turn raises the clinical urgency to adopt of this stimulation device in aforementioned indications. Rise in the geriatric population base, which is more susceptible to neurological disorders is also a high impact growth rendering driver.

Also, coupled with advent of innovative and cost efficient technology for management of neurological disorders and chronic pain is expected to boost the growth potential throughout the forecast period. The advent of technologically advanced and sophisticated products such as implantable pulse generator (IPG) and consistent increase in R&D activities are projected to further impel lucrative opportunities in future. IPG helps in efficient stimulation and provides varied proportions of electric current in between leads which are multi polar. The efficacy can also be increased with the use of feedback signals which are computer based to reduce risk of side effects.

Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/deep-brain-stimulators-dbs-market/request-sample

According to a report by Parkinson’s disease Foundation, the risk of Parkinson’s increases with increase in age with the median age for the disease being 55 to 60. Also, the high prevalence of target diseases has a significant impact on the growth on the DBS industry. The inadequate efficacy associated with oral therapeutics, for instance, dopamine and its associated adverse effects are the major causes for the surge in adoption of DBS.

Application Insights
The deep brain stimulators are commonly used for Parkinson’s disease owing to its ability to keep track of symptom fluctuations which are short-lived as the disease progresses. The use of DBS shows higher efficacy when compared to other oral medication available, hence leading to dominant market share. In terms of revenue generated in 2016, Parkinson’s disease is followed by OCD and dystonia. The higher number of benefits associated with this treatment is also major contributor for the share registered by Parkinson disease in the application segment. These include improvement in motor symptoms for longer duration, increased relief from other non motor symptoms such as sleep disturbances and muscle cramps.

Browse Full Research Report @
https://www.millioninsights.com/industry-reports/deep-brain-stimulators-dbs-market

Other benefits include minimum incidences of drug induced adverse effects including dyskinesia and lower dose of medication thereby resulting in greater adoption of DBS in comparison with conventional therapeutic options. The life quality is also enhanced with use of beep brain stimulators due to improvement in motor symptoms. The aforementioned factors are the key driving factor for market growth throughout the forecast period. Moreover, DBS finds use in pain management and increasingly used for treating epilepsy in the regional market of Europe is projected to drive the market in future. The continuous research for its usage in newer array of applications is projected to further impel market growth.

Regional Insights
The overall market was dominated by North American region in 2016 with share of over 50.0%. The high share can be attributed to various factors such as favorable healthcare infrastructure and supportive reimbursement policies of the region. Rise in awareness related to application and benefits associated with them are major contributors to the share attained by North America over the previous years. Asia Pacific is expected to witness exponential CAGR throughout the forecast period. Moreover, the pending approval for commercialization of DBS for epilepsy treatment by U.S.FDA is anticipated to further strengthen regional consumer base. Increasing disposable income, consistent rise in patient awareness and high healthcare expenditure of emerging countries is predicted to present with high potential growth prospects across Asia Pacific.

See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices

Competitive Insights
The prominent players in the market include Aleva Neurotherapeutics SA, Boston Scientific, St. Jude Medical Inc. and Medtronic Plc. The nature of the industry is oligopolistic with a rise in focus by key players on providing advance technologies to maintain their competitive edge and increase penetration. Various strategies adopted by the major manufacturers are promoting awareness level amongst patients as well as healthcare professionals. This is achieved with the help of promotional campaigns which will be fruitful to increase acceptance of deep brain stimulators in the future.

For More Detailed Analysis Visit @ Million Insights

Fixed And Mobile C-arms Market Growth Prospect and Insights Overview by 2025

Industry Insights
The Global Fixed and Mobile C-Arms Market size was valued at around USD 1.68 billion in 2016 and is expected to grow at a CAGR of 3.4% over the forecast period. C-arms have a wide application in clinical imaging in terms of its navigation and clear imaging. Mobile C-arms are exhibiting the fastest growth in this sector due to its mobility, flexibility and ease of use. As the technology is advancing and newer accessories are being developed in the medical devices sector, mobile C-arms are continuously providing precise images with greater depth which would in turn help in getting faster and accurate diagnostic results. Growing prevalence of geriatric population and rising orthopedic, respiratory and cardiovascular conditions globally are expected to boost growth of the market.

Other factors, which is leading to such growth in the market, are increasing patient awareness, advancing technology, 3D visualization and greater accessibility of patients for improved healthcare facilities. Government bodies of developing countries such as India, Mexico, and Brazil, are making huge investments to spread awareness regarding the application of C-arms, thereby focusing on patient-centric care. These devices provide real-time detailed imaging of the anatomy and the real positing of the various organs, which proves to be helpful before various complicated surgeries. Regions such as Latin America, Middle East and Asia Pacific is witnessing increase in foreign investments, which is leading to revenue generation, hence contributing to the market growth.

Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/fixed-mobile-c-arms-market/request-sample

Product Insights
For healthcare setting which are of low budget and do not have much financial resources, are opting for mobile C-arms device. The device has proved to be one of the prime medical diagnostic devices, leading to fastest anticipated growth. Few other factors contributing towards the segment’s fast growth include high quality images, optimum and appropriate angle positioning with flexible movement and improved patient compliance. Mobile C-arms are further categorized into full size and mini size C-arms. Full size C-arms has been observed to mark the most dominating market because of its wide application, and greater availability in the market.

Application Insights
In the year 2016, orthopedics and trauma segment dominated the Fixed & Mobile C-arms Market market due to the device’s accurate image capturing capability with flexible positioning, efficiency, and versatility. Products from Siemens Healthineers such as cios Fusion, cios Select and cios Alpha have successfully led and dominated the market in orthopedic sector due to its wide applications in the operating rooms. The pain management market is estimated to witness the highest growth during the forecast period due to faster workflow, greater maneuverability and higher resolution.

Browse Full Research Report @
https://www.millioninsights.com/industry-reports/fixed-mobile-c-arms-market

Regional Insights
North America dominated the C-arms industry with largest revenue share in 2016. Widening application areas of C-arms and increasing number of people suffering from orthopedic disorders are some of the factors responsible for the dominant growth of the market in this region. In addition, North America is home to some of the most significant players who are operating in the field of C-arms market.

On the other hand, Asia Pacific is expected to exhibit fastest growth during the forecast period. There has been rapid adoption of Fixed And Mobile C-arms Market in the diagnosis and treatment of a number of medical conditions, which is anticipated to fuel growth of the market in the region. Furthermore, increasing number of cardiovascular and orthopedic surgeries in countries such as China and Japan is expected to drive growth of the market in Asia Pacific region.

See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices

Competitive Insights
Currently, the Fixed & Mobile C-arms Market is consolidated in nature with a few players dominating the market. Some of the top companies operating in this industry are Ziehm Imaging; Hitachi Medical Systems; Toshiba Medical Systems; OrthoScan, Inc.; and others. A huge number of companies are focusing towards the advancement of C-arms device technology. Companies are adding X-ray intensifier to their product portfolio in order to capture the largest market share. The most common strategy opted by companies are mergers, acquisitions and collaboration in order to gain maximum share in the market.

For More Detailed Analysis Visit @ Million Insights

Ophthalmic Lasers Market : Global Industry Analysis and Opportunity Assessment by 2025

Industry Insights
The Global Ophthalmic Lasers Market size was worth USD 1.0 billion in 2016, which is anticipated to grow at a CAGR of more than 5.9% during the forecast period. Increase in incidence of chronic ophthalmic disorders is the major driving factor contributing to the growth of ophthalmic lasers market. There is a rise in prevalence of ophthalmic disorders such as glaucoma, cataract, refractive errors, Age Related Macular Degeneration (AMD), retinal disorders and diabetic retinopathy. According to American Academy of Ophthalmology in 2014, 60.5 million people were estimated to be suffering from glaucoma globally. According to WHO, glaucoma is the second major cause of blindness in the world.

Based on the Journal of Ophthalmology, cataract is the leading cause of blindness in the world. According to New-Medical .Net, in 2015, 22 million people aged 40 years and above were affected with cataract. According to National Eye Institute, by 2050, the number of people in US with cataract is estimated to double from 24.4 million to around 50 million. Thus, with the rise in incidence of ophthalmic disorders the market is estimated to witness rapid growth during the forecast period. According to a study conducted by PLOS, in UK approximately 54% of the people aged 40-69 years were affected by refractive error of which 27% of the people had myopia. Refractive error is a major health issue in UK.

Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/ophthalmic-lasers-market/request-sample

It is a genetic disorder, so the individuals whose parents are suffering from any form of refractive disorder are likely to be affected by similar disorder. Thus, the aforementioned factors are supporting the growth of the ophthalmic lasers market. Increase in geriatric population is another key factor driving the growth of the market. This group of population is generally affected by various eye disorders. The most common eye disorders for this group are cataract and hyperopia.

Product Insights
In the product segment, femtosecond lasers held the largest revenue share in 2016. The rising number of people affected by refractive disorders along with its use during cataract surgeries has led to the growth of the market. Rise in technological advancements, versatility, predictability, and the unique properties offered by the femtoseconds lasers has increased its demand. Thus, newer technologies are contributing to the growth of the market. Excimer laser is a form of ultraviolet laser, which is used for the treatment of refractive errors. For instance, Carl Zeiss Meditec AG launched MEL 80 Excimer for refractive laser surgery.

This device in combination with femtosecond laser helps in correcting refractive errors. These lasers account for a considerable share owing to its increased usage in healthcare facilities. SLT and YAG lasers are used for the treatment of anterior segment of the eye. It helps in treatment of glaucoma, retina and corneal surgery by reducing the intra ocular pressure. Ellex Medical Lasers Limited has a wide range of SLT and YAg lasers for the treatment of eye disorders. These lasers are anticipatedto grow at significant rate over the forecast period.

Browse Full Research Report @
https://www.millioninsights.com/industry-reports/ophthalmic-lasers-market

Application Insights
On the basis of application, refractive error corrections dominate the market in 2016. Rising incidence of refractive errors in children and geriatric population has contributed towards the growth of this segment. In addition, use of femtoseconds lasers in correcting eye disorders have also contributed to the growth of this segment. Cataract removal is expected to witness fastest growth over the forecast period due to the increasing number of cataract removal surgeries taking place across the globe. Cataract is a common problem in the geriatric population which is the leading cause of blindness, if not given proper care at the right time. Glaucoma is the second leading cause of blindness, if not given proper medical attention.

This has eventually contributed to the increased the demand for SLT and YAG lasers. Lumenis introduced a product, Smart Select Duet, which uses the combination of SLT and YAG lasers for treating glaucoma. Retinal disease such as AMD and diabetic retinopathy are the common problem of geriatric population. According to the American Academy of Ophthalmology, 60% of people with diabetes develop diabetic retinopathy. The major players are focussing on production of products which are helpful in correcting such eye disorders. For instance, Topcon Corporation manufactured PASCAL Synthesis System for the treatment diabetic retinopathy and AMD.

End use Insights
On the basis of the end-use, hospital held the largest market share in 2016 due to the large number of ophthalmic lasers being performed in hospitals. The rising number of hospitals in the developing countries with the support of the government also contributes to the growth of this segment. Ambulatory surgical centres are expected to witness significant growth over the forecast period. The increasing initiatives for awareness undertaken by the government in the developing countries contributes to the growth of this segment. Ophthalmic clinics are expected to show fastest growth over the forecast period. This is due to the rise in number of speciality clinics which can treat chronic conditions and the personal care given to the patients.

See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices

Regional Insights
North America dominated the market in 2016 due to the rising healthcare expenditure and development of healthcare infrastructure in the US. The rising incidence of diabetes in America also contributes to the growth of ophthalmic disorders which in turn is anticipated to flourish the regional market. Europe also contributes to a significant share of the market in 2016, due to the increase in geriatric population. Increase in ophthalmic disorders among this population group is expected to support the regional market growth. Asia Pacific is expected to show an attractive growth over the forecast period due to increase in healthcare expenditure in developing countries such as India and China.

Competitive Insights
Some of the major players of the market include Alcon Laboratories, Inc., Carl Zeiss Meditec AG, Ellex Medical Lasers Limited, Abbott Medical Optics, Inc., Bausch & Lomb Incorporated, Topcon Corporation, IRIDEX Corporation, Lumenis, Ziemer Ophthalmic Systems AG, and NIDEK Co., Ltd. The major strategies of the key players include mergers & acquisitions, new product development, and regional expansions. For instance, in 2015, Topcon Corporation redesigned Next Generation Pattern Scanning Laser PASCAL Synthesis with an automatic table, which helps in efficiency and space savings.

For More Detailed Analysis Visit @ Million Insights